Abstract
Objective: To study the clinical significance of multidrug resistance gene expression in acute leukemia. Methods: The relationships between drug resistance of leukemia cells and prognosis, multidrug resistance gene (mdr1) were examined in 85 patients with acute leukemia and 20 normal controls by reverse transcriptase poly-merase chain reaction (RT-PCR). Results: The mdrl positive rate in untreated group was 44.7%. The complete remission (CR) rate of mdr1 positive patients (23.9%) was significantly lower than that of mdr1 negative patients (88.5%) (P<0.005). The mdr1 expression level in relapsed-refractory group was higher than that of CR group. A gradually increased mdr1 mRNA level in CR patients indicated early relapse. Conclusion: The mdr1 positive rate in normal control and long-term survival patients was very low. The mdr1 expression was correlated with French-American-British Cooperative Group (FAB) classification. The mdr1 expression level was correlated with chemotherapeutic effect and prognosis. It is an unfavorable prognostic factor for patients with acute leukemia.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Noonan KE, Beck C, Holzmayer TA, et al. Quantitative analysis of mdr1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc Natl Acid Sci USA 1990; 87:7100.
Nooter K, Sonneveld P. Clinical relevance of P-glycoprotein expression in haematological malignancies. Leuk Res 1994; 16:233.
Campos L, Gugotat D, Archimband E, et al. Clinical significance of multidrug resistance P-glycoprotein expression on acute nanlymphoblastic leukemia cells at diagnosis. Blood 1992; 79:473.
Poeta GD, Stasi R, Venditti A, et al. Prognostic value of cell marker analysis in devote acute myeloid leukemia. Leukemia 1994; 8:388.
Nooter K, Sonneveld P. Expression of the mdr3 gene in prolymphocytic leukemia: association with cyclosporin-A-induced increase drug accumulation. Int J Cancer 1990;45:626.
Schinkel AH, Roelofs MEM, Borst P. Characterization of the human mdr3 P-glycoprotein and its recognition by P-glycoprotein specific monoclonal antibodies. Cancer Res 1991; 51:2628.
Teboekhorst PAW, Wittebol S, Hagemeijer A, et al. Predominance of the multidrug resistance phenotype in acute myeloid leukemia cells is associated with an immature (CD34+) phenotype. Blood 1993; 82:3157.
List AF, Spier CM. Multidrug resistance in acute leukemia: a conserved physiologic function. Leukemia and Lymphoma 1992; 8:9.
Drach D, Zhao S, Drach J, et al. Low incidence of MDR-1 expression in acute promyelocytic leukemia. Br J Haematol 1995; 90:369.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dong, Z., Luo, J., Xu, W. et al. The clinical significance of multidrug resistance gene (mdr1) expression in acute leukemia. Chin J Cancer Res 10, 59–62 (1998). https://doi.org/10.1007/BF02974662
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02974662